Neweast Biosciences

Neweast Biosciences, located in King of Prussia, PA, specializes in the research and development of innovative antibodies targeting GTPases and mutated oncogenes. With over a decade of expertise, the company offers unique antibody products that recognize the active forms of GTPases and mutated oncogenes while achieving high affinity for cAMP and cGMP without the need for acetylation.

Their extensive product portfolio includes bioactive transmembrane proteins, novel virus-like particles, and a range of reagents designed for drug discovery and research applications. Neweast Biosciences is dedicated to advancing scientific knowledge, as demonstrated by their citation in over one thousand peer-reviewed articles across leading journals.

Generated from the website